1 results match your criteria: "Liverpool Women's Hospital Crown Street[Affiliation]"
mRECIST criteria and contrast-enhanced US for the assessment of the response of hepatocellular carcinoma to transarterial chemoembolization.
Diagn Interv Radiol
May 2015
Departments of Radiology (H.M. e-mail: M.G.P., I.K.) and Urology (K.S.), General Hospital Tzanio, Piraeus, Greece; the 2nd Department of Radiology (K.M., K.C., N.K.), University of Athens, Attikon Hospital, Athens, Greece; the Department of Gynecology (A.A.), Liverpool Women's Hospital Crown Street, Liverpool, UK.
Purpose: We aimed to evaluate the combination of the modified Response Evaluation Criteria In Solid Tumors (mRECIST) and contrast-enhanced ultrasonography (CEUS) as a tool for the assessment of hepatocellular carcinoma treated with transarterial chemoembolization.
Materials And Methods: Forty-seven hepatocellular carcinoma patients (80 target tumors suitable for mRECIST measurements) were studied. They were treated with scheduled transarterial chemoembolization with doxorubicin-eluting microspheres every 5-7 weeks.